Humacyte Inc (HUMA)
3.20 x 16 3.32 x 1
Post-market by (Cboe BZX)
3.32 +0.14 (+4.40%) 03/21/25 [NASDAQ]
3.20 x 16 3.32 x 1
Post-market 3.21 -0.11 (-3.31%) 18:59 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | HUMA | DNA | RNAC | ||
| Company | Humacyte Inc | Ginkgo Bioworks Hldgs Inc | Cartesian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 3.15 | 7.00 | 16.37 | ||
| High | 3.35 | 7.37 | 16.79 | ||
| Low | 3.13 | 6.89 | 15.80 | ||
| Last | 3.32 | 7.27 | 16.05 | ||
| Change | +0.14 | +0.10 | +0.12 | ||
| % Change | +4.40% | +1.39% | +0.75% | ||
| Volume | 2,195,000 | 1,872,700 | 125,400 | ||
| 20-Day Average Volume | 2,388,080 | 1,748,465 | 106,560 | ||
| Previous Close | 3.18 | 7.17 | 15.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.13 | 7.87 | 17.24 | ||
| 20-Day Raw Stochastic | 47.90% | 19.75% | 41.82% | ||
| 20-Day Relative Strength | 46.01% | 40.42% | 41.73% | ||
| Weighted Alpha | -34.69 | -79.86 | -41.05 | ||
| Today's Opinion | 88% Sell | 56% Sell | 100% Sell | ||
| Previous Opinion | 88% Sell | 56% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 32% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.21% since 03/14/25 | +4.30% since 03/14/25 | +1.58% since 03/14/25 | ||
| Low | 2.87 on 03/17/25 | 6.89 on 03/21/25 | 13.57 on 03/18/25 | ||
| High | 3.35 on 03/21/25 | 8.02 on 03/17/25 | 16.79 on 03/21/25 | ||
| 1-Month | |||||
| %Chg | -6.21% since 02/21/25 | -32.81% since 02/21/25 | -16.58% since 02/21/25 | ||
| Low | 2.75 on 03/13/25 | 6.33 on 03/13/25 | 13.57 on 03/18/25 | ||
| High | 3.94 on 02/27/25 | 11.09 on 02/24/25 | 19.50 on 02/25/25 | ||
| 3-Month | |||||
| %Chg | -28.45% since 12/20/24 | -27.88% since 12/20/24 | -15.62% since 12/20/24 | ||
| Low | 2.75 on 03/13/25 | 6.33 on 03/13/25 | 13.57 on 03/18/25 | ||
| High | 5.66 on 12/27/24 | 16.85 on 02/06/25 | 20.30 on 12/24/24 | ||
| 6-Month | |||||
| %Chg | -36.15% since 09/20/24 | -9.24% since 09/20/24 | +0.12% since 09/20/24 | ||
| Low | 2.75 on 03/13/25 | 6.01 on 11/15/24 | 13.57 on 03/18/25 | ||
| High | 6.77 on 12/20/24 | 16.85 on 02/06/25 | 26.50 on 12/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 417,852 | 421,907 | 415,807 | ||
| Shares Outstanding, K | 125,859 | 58,034 | 25,907 | ||
| Annual Sales | 0 | 227,040,000 | 38,910,000 | ||
| Annual Net Income | -110,780,000 | -547,030,000 | -77,420,000 | ||
| Last Quarter Sales | 0 | 43,850,000 | 390,000 | ||
| Last Quarter Net Income | -39,200,000 | -107,530,000 | -24,180,000 | ||
| 60-Month Beta | 1.36 | 1.23 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 11/08/24 | -1.82 on 02/25/25 | -0.69 on 11/07/24 | ||
| Latest Earnings Date | 03/28/25 | 05/08/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||